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Fever is one of the more common chief complaints 
of patients who visit the emergency department (ED).
As the cause of fever may be the common cold or fatal
sepsis, it is a great challenge to emergency room physi-
cians to make the correct diagnosis. In addition to the
patient’s symptoms and signs, many tests are used to
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Fever is one of the more common chief complaints of patients who visit emergency departments
(ED). Many febrile patients have markedly elevated C-reactive protein (CRP) levels and normal
white blood cell (WBC) counts. Most of these patients have bacterial infection and no previous
underlying disease of impaired WBC functioning. We reviewed patients who visited our ED
between November 2003 and July 2004. The WBC count and CRP level of patients over 18 years
of age who visited the ED because of or with fever were recorded. Patients who had normal WBC
count (4,000–10,000/μL) and high CRP level (> 100 mg/L) were included. The data, including
gender, age and length of hospital stay, were reviewed. Underlying diseases, diagnosis of the
febrile disease and final condition were recorded according to the chart. Within the study period,
54,078 patients visited our ED. Of 5,628 febrile adults, 214 (3.8%) had elevated CRP level and nor-
mal WBC count. The major cause of febrility was infection (82.24%). Most of these patients were
admitted (92.99%). There were 32 patients with malignant neoplasm, nine with liver cirrhosis, 66
with diabetes mellitus and 11 with uremia. There were no significant differences in age and gen-
der between patients with and those without neoplasm. However, a higher inhospital mortality
rate and other causes of febrility were noted in patients with neoplasm. It was not rare in febrile
patients who visited the ED to have a high CRP level but normal WBC count. These patients did
not necessarily have an underlying malignant neoplasm or hematologic illness. Factors other
than malignant neoplasm or hematologic illness may be associated with the WBC response, and
CRP may be a better indicator of infection under such conditions.
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examine febrile patients. Sometimes, they have signif-
icant symptoms and signs, and the diagnosis can be
made by suitable examination. On other occasions,
however, patients do not have obvious symptoms and
signs, although physicians need an indicator to avoid
a failure to diagnose severe disease.
In febrile patients, white blood cell (WBC) count
is a common examination. In addition, procalcitonin,
C-reactive protein (CRP) and interleukin-6 levels will
be elevated in cases of severe infection [1–7]. Some
studies suggest that these examinations could help to
differentiate between less threatening fever and septic
patients. CRP is a common available examination item
in Taiwan’s hospitals. In practice, however, WBC count
and CRP are not always elevated at the same time
[8–10]. Some obviously septic patients do not have ele-
vated WBC count but their CRP is markedly elevated.
Such a condition can also be found in some patients
with hematologic disease and neoplasm [11,12].
We found that many patients without hematologic
disease and neoplasm have normal WBC count and
markedly elevated CRP. These patients usually have
obvious infection or inflammation. Therefore, we ana-
lyzed the characteristics of these patients, and then
compared them with those of patients with malignancy.
METHODS
We retrospectively reviewed patients who visited the
ED of Kaohsiung Medical University Hospital between
November 2003 and July 2004 because of fever or high
body temperature (tympanic temperature > 38.3°C).
Because the period of study was within 1 year of the
severe acute respiratory syndrome (SARS) outbreak, all
febrile patients received blood examinations including
WBC count and CRP level. Adult patients (> 18 years)
who had normal WBC counts (4,000–10,000/μL) and
high CRP levels (>100mg/L) were included for further
analysis. Patient characteristics including gender and
age were recorded. Underlying diseases including dia-
betes mellitus, end-stage renal disease, liver cirrhosis
and malignant neoplasm were recorded by history
taking and examination in hospital. The diagnosis and
final condition on discharge from hospital were deter-
mined according to the chart records filled in by the
doctor in charge of the ward or ED. Student’s t test was
used to compare age and days of hospitalization 
between patients with and those without underlying
malignant neoplasm and/or hematologic disease. 
χ2 and Fisher’s exact tests were used to examine the
correlation between gender, cause of fever, hospital-
ization, type of infection and mortality with underly-
ing malignant neoplasm and/or hematologic disease. 
RESULTS
Within the study period, 54,078 patients visited our
ED. Of 5,628 febrile adults, 214 (3.8%) had an elevated
CRP level and normal WBC count. The age of these
patients ranged from 20 to 97 years. The characteris-
tics of these patients are shown in Table 1. There were
32 patients with malignant neoplasm, nine with liver
cirrhosis, 66 with diabetes mellitus and 11 with uremia.
The major cause of febrility was infection (82.24%).
Pneumonia and urinary tract infection were the leading
diagnoses of infection (Table 2). Most of the patients
Table 1. Characteristics of patients with high C-reactive
protein levels and normal white blood cell counts*
Age (yr) 61.9 ± 18.2
Gender
Female 96 (44.86)
Male 118 (55.14)
Underlying disease
Malignancy 32 (14.95)
Liver cirrhosis 9 (4.21)
Diabetes mellitus 66 (30.84)
Uremia 11 (5.14)
*Data presented as mean ± standard deviation or n (%).
Table 2. Causes of febrility and patient outcome*
Infection 176 (82.24)
Infection focus
Urinary tract 44 (25)
Lung & bronchus 70 (39.77)
Gastrointestinal tract 10 (5.68)
Soft tissue 9 (5.11)
Liver 12 (6.82)
Multisite 11 (6.25)
Others 20 (11.36)
Number of hospitalizations 199 (92.99)
Days of hospitalization 14.06 ± 12.91
Mortality 9 (4.52) 
*Data presented as n (%) or mean ± standard deviation.
Kaohsiung J Med Sci May 2008 • Vol 24 • No 5250
K.T. Liu, T.J. Lin, and H.M. Chan
were admitted (92.99%). There were no significant dif-
ferences in age and gender between patients with and
those without neoplasm (Table 3). However, a higher
inhospital mortality rate and other causes of febrility
were noted in patients with neoplasm. 
DISCUSSION
Febrile patients who have normal WBC counts and
elevated CRP levels usually have infection (82.24%).
CRP is an acute-phase reactant produced by the liver
that can increase markedly in response to infection 
or inflammation. In a previous study [13], markedly
increased CRP level (>100mg/L) was highly associated
with severe sepsis. This makes it possible to distinguish
pyelonephritis from cystitis, bacterial pneumonia from
acute bronchitis, acute bronchitis from uncomplicated
acute or chronic obstructive pulmonary disease, and
bacterial meningitis from aseptic meningitis. However,
the range of elevation is large: the higher the CRP
level, the more sensitivity there is to an association
with sepsis. For this reason, a cutoff point of 100 mg/L
was selected in this study for its higher ability to
detect the factor results in normal WBC counts in
those patients. In Putto et al’s study [14], CRP of
> 40 mg/L could detect 79% of bacterial infection
with 90% specificity. However, CRP of 20–40 mg/L
has been recorded in both viral and bacterial infec-
tions. Many studies found that CRP was more sensi-
tive than WBC counts in distinguishing bacterial
infection [1,10].
Many studies have focused on the use of CRP in
patients with malignancy, hematologic disease or neu-
tropenia, because these patients do not have normal
WBC response to infection [3,4,12,15–22]. Such studies
have shown that CRP could help to diagnose sepsis
in such patients. In a study of children with cancer,
Santolaya et al [18] showed that patients with CRP
level > 40 mg/L had bacterial infection (sensitivity of
100%, specificity of 76.6%). Arber et al [12] found that
levels of CRP in sepsis were higher than in graft-versus-
host disease. Although CRP is elevated in cancer itself,
fever with elevated CRP could still reveal infection.
Most of the patients in our study did not have malig-
nancy or hematologic disease, but WBC count did not
increase in those with infections. Although some of
these patients had chronic disease, further study is
needed to determine the cause of impaired WBC re-
sponse in these patients. Other biomarkers like CRP
may be more suitable to detect infection in such
patients. In our study, there were no differences in age
and gender between patients with and those without
malignancy. Although most causes of febrility were
infection in both types of patients, patients with malig-
nancy still had higher incidences of causes of febrility
other than infection. The inhospital mortality rate was
higher in patients with malignancy. Our data did not
attribute the mortality to the difference in severity of
infection or underlying malignancy. The patients with
malignancy had a greater possibility of having a rare
infection or multiple site infection.
As fever is one of the most common complaints 
of patients who visit the ED, it is very important to
Table 3. Comparison of characteristics and outcomes between patients with and those without malignancy*
With malignancy (n = 32) Without malignancy (n = 182) p
Age (yr) 61.9 ± 19.3 61.8 ± 10.6 0.969†
Male gender 17 (53.1) 101 (55.5) 0.804‡
Infection 19 (59.4) 157 (86.3) < 0.005‡
Infection focus < 0.005‡
Urinary tract 3 (15.8) 41 (26.1)
Lung & bronchus 10 (52.6) 60 (38.2)
Multisite 5 (26.3) 6 (3.8)
Others 1 (5.3) 50 (31.8)
Hospitalization 30 (93.8) 169 (92.9) 0.855‡
Days of hospitalization 17.4 ± 12.2 13.5 ± 13.4 0.131†
Mortality 4 (13.3) 5 (3) 0.031‡
*Data presented as mean ± standard deviation or n (%); †t test; ‡χ2 test or Fisher’s exact test.
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determine whether the cause is severe infection or
inflammation. Many standard medical tests have aided
clinical diagnosis, such as WBC counts, interleukin-6,
interleukin-8, CRP, procalcitonin, soluble Fcγ recep-
tor type III and mannose-binding protein [1,4,5,7,23].
Although studies have shown the value of these exam-
inations, the majority, except for CRP and WBC count,
are unavailable in the ED of most hospitals. Most
infections can be diagnosed by clinical symptoms and
signs, but diagnosis may be difficult in patients who
cannot express their symptoms well, such as children.
Accordingly, CRP could be used in febrile children
[1,7,16,18,23–26] to distinguish bacterial infection.
Furthermore, the causes of febrility may be difficult
to distinguish in some situations including trauma
[27] and bone marrow transplantation [12]. The CRP
level test has value in such cases. Furthermore, many
infectious or inflammatory diseases have no specific
symptoms; marked elevation of CRP has significant
diagnostic value in such cases as well.
There are several limitations to this study. First,
the major goal of the study was to analyze the charac-
teristics of febrile patients with normal WBC count
and high CRP level. We lacked the data to confirm
the roles in differential sepsis in this study. Secondly,
this study did not determine whether CRP itself
affects the disposition of the doctors. Further study is
necessary to determine if doctors tend to suggest that
patients with high CRP level be hospitalized. Finally,
this study analyzed the data in an ED, so the results
can be applied to patients in an ED, but it did not deter-
mine if these patients had normal WBC counts through-
out the course of disease or whether some patients
developed high CRP levels during the course of the
disease.
It was not rare for febrile patients who visited 
the ED to have high CRP level but normal WBC
count. These patients usually had significant infection
or inflammation and needed hospitalization and fur-
ther treatment, but they did not necessarily have an
underlying malignant neoplasm or hematologic illness.
This suggests that some factors other than malignant
neoplasm or hematologic illness may be associated
with the WBC response, and that CRP may be a better
indicator of infection under such conditions. Further
studies are needed to elucidate what these factors
may be. We believe that it is reasonable to check CRP
level in addition to WBC count for patients who visit
the ED due to fever.
REFERENCES
1. Galetto-Lacour A, Zamora S, Gervaix A. Bedside procal-
citonin and C-reactive protein tests in children with fever
without localizing signs of infection seen in a referral
center. Pediatrics 2003;112:1054–60.
2. Kawasaki Y, Hosoya M, Katayose M, et al. Correlation
between serum interleukin 6 and C-reactive protein
concentrations in patients with adenoviral respiratory
infection. Pediatr Infect Dis J 2002;21:370–4.
3. Kallio R, Bloigu A, Surcel H, et al. C-reactive protein
and erythrocyte sedimentation rate in differential diag-
nosis between infections and neoplastic fever in patients
with solid tumours and lymphomas. Support Care Cancer
2001;9:124–8.
4. Engel A, Mack E, Kern P, et al. An analysis of interleukin-
8, interleukin-6 and C-reactive protein serum concen-
trations to predict fever, gram-negative bacteremia and
complicated infection in neutropenic cancer patients.
Infection 1998;26:213–21.
5. Herrmann J, Blanchard H, Brunengo P, et al. TNF alpha,
IL-1 beta and IL-6 plasma levels in neutropenic patients
after onset of fever and correlation with the C-reactive
protein (CRP) kinetic values. Infection 1994;22:309–15.
6. Fassbender K, Pargger H, Muller W, et al. Interleukin-6
and acute-phase protein concentrations in surgical
intensive care unit patients: diagnostic signs in nosoco-
mial infection. Crit Care Med 1993;21:1175–80.
7. Lehrnbecher T, Venzon D, de Haas M, et al. Assess-
ment of measuring circulating levels of interleukin-6,
interleukin-8, C-reactive protein, soluble Fc gamma
receptor type III, and mannose-binding protein in febrile
children with cancer and neutropenia. Clin Infect Dis
1999;29:414–9.
8. Verkkala K, Valtonen V, Jarvinen A, et al. Fever, leuco-
cytosis and C-reactive protein after open-heart surgery
and their value in the diagnosis of postoperative infec-
tions. Thorac Cardiovasc Surg 1987;35:78–82.
9. Gozzard D, Yin J, Delamore I. The clinical usefulness 
of C-reactive protein measurements. Br J Haematol 1986;
63:411–4.
10. Povoa P, Almeida E, Moreira P, et al. C-reactive protein 
as an indicator of sepsis. Intensive Care Med 1998;24:
1052–6.
11. Grutzmeier S, von Schenck H. C-reactive protein dur-
ing chemotherapy for acute leukemia with special refer-
ence to non-infective causes of fever. Med Oncol Tumor
Pharmacother 1986;3:71–5.
12. Arber C, Passweg J, Fluckiger U, et al. C-reactive protein
and fever in neutropenic patients. Scand J Infect Dis
2000;32:515–20.
13. Morley J, Kushner I. Serum C-reactive protein levels in
disease. Ann NY Acad Sci 1982;389:406–18.
14. Putto A, Ruuskanen O, Meurman O, et al. C reactive
protein in the evaluation of febrile illness. Arch Dis Child
1986;61:24–9.
15. Timonen T, Koistinen P. C-reactive protein for detec-
tion and follow-up of bacterial and fungal infections in
Kaohsiung J Med Sci May 2008 • Vol 24 • No 5252
K.T. Liu, T.J. Lin, and H.M. Chan
severely neutropenic patients with acute leukaemia. 
Eur J Cancer Clin Oncol 1985;21:557–62.
16. Katz J, Mustafa M, Bash R, et al. Value of C-reactive
protein determination in the initial diagnostic evaluation
of the febrile, neutropenic child with cancer. Pediatr
Infect Dis J 1992;11:708–12.
17. Rintala E, Irjala K, Nikoskelainen J. Value of measure-
ment of C-reactive protein in febrile patients with hema-
tological malignancies. Eur J Clin Microbiol Infect Dis
1992;11:973–8.
18. Santolaya M, Cofre J, Beresi V. C-reactive protein: a valu-
able aid for the management of febrile children with
cancer and neutropenia. Clin Infect Dis 1994;18:589–95.
19. Gunther G, Gardlund B, Hast R, et al. Endotoxaemia
and inflammatory mediators in febrile patients with
haematological disease. J Intern Med 1995;237:27–33.
20. Manian F. A prospective study of daily measurement of
C-reactive protein in serum of adults with neutropenia.
Clin Infect Dis 1995;21:114–21.
21. Kostiala A, Kostiala I, Valtonen V, et al. Levels of 
C-reactive protein in patients with hematologic malig-
nancies. Scand J Infect Dis 1985;17:407–10.
22. Harris R, Stone P, Hudson A, et al. C reactive protein
rapid assay techniques for monitoring resolution of
infection in immunosuppressed patients. J Clin Pathol
1984;37:821–5.
23. Heney D, Lewis I, Evans S, et al. Interleukin-6 and 
its relationship to C-reactive protein and fever in chil-
dren with febrile neutropenia. J Infect Dis 1992;165:
886–90.
24. Lembo R, Marchant C. Acute phase reactants and risk
of bacterial meningitis among febrile infants and chil-
dren. Ann Emerg Med 1991;20:36–40.
25. Gervaix A, Galetto-Lacour A, Gueron T, et al. Usefulness
of procalcitonin and C-reactive protein rapid tests for
the management of children with urinary tract infection.
Pediatr Infect Dis J 2001;20:507–11.
26. Pulliam P, Attia M, Cronan K. C-reactive protein in
febrile children 1 to 36 months of age with clinically
undetectable serious bacterial infection. Pediatrics 2001;
108:1275–9.
27. Miller P, Munn D, Meredith J, et al. Systemic inflamma-
tory response syndrome in the trauma intensive care
unit: who is infected? J Trauma 1999;47:1004–8.
Kaohsiung J Med Sci May 2008 • Vol 24 • No 5 253
 !"VS==S==ON=
 !"VS==NO==OQ=
 !"#$%&'
 !"!#$ %&'(
 UMT !"#$NMM
=`= !"#$!%&'()*
 !"#
 
N
= = 
NIO
= = 
NIP
N
 !"!#$ %= = 
 !"!= = != =
O
 = =
P
 
 !"#$#%&'()*+,-./0123%4/=`= !"#$%&
 !"#$%&"'()*+,-./01234' !567$'89:
 !"#$%=OMMPKNN==OMMQKT= !"#$#%&'(NU= !"
 !=`= !"#$=NMM=ãÖLi= !"#$%I !"#$%&'
 !I !"#$%&'()*+,&-./0123456789:;<
RQIMTU= !"#$%&%'()*=RISOU= !"#$%&'(=ONQ=EPKUBF
 !"#$%&'(=`= !"#$%&!'()*+,-./0123&
 !"=EUOKOQBF !"#$%&=EVOKVVBF !=PO= !"#$V
 !"#SS= !"#=NN= !"#$%&'()*+,-./01
 !"#$%&'()*!+,-./-01234'#5)36789:-;
 !"#$%&'()*+,-./012=`= !"#$%&'()*
 !"#$%&'()*+,-./012345 67819$:;<=
 !"#$%&'()* !"+,-./0123456789:;=`
 !"#$%&'()*+,-./0123
 `= !"#$"%&
E !=OMMUXOQWOQURPF
